Position in RPRX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$20,914
+$1,631 QoQ
Shares Held
373
-7.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#563
of 645 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cornerstone Planning Group LLC holds $333,862 across 45 Biotechnology names. RPRX ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
130 | $64,574 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
199 | $37,268 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
389 | $30,447 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
97 | $29,199 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
373 | $20,914 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
300 | $16,362 | |
| 7 | ARGX |
Argenx SE
|
17 | $15,772 | |
| 8 | ABCL |
AbCellera Biologics Inc.
|
2,000 | $15,700 |
All Filings in RPRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,914 | 373 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $19,283 | 402 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $11,437 | 296 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $18,733 | 531 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $4,503 | 125 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,113 | 100 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,198 | 47 | Shares | Sole | 2025-01-29 | |
| No filing history on record for this holder in this stock. | ||||||